Spero Therapeutics, Inc. (20) | Intellectual Property (2)
- Amended and Restated License Agreement, dated January 15, 2021, by and between the Registrant and Everest Medicines II Limited (Filed With SEC on March 11, 2021)
- License Agreement, dated January 4, 2019, by and between New Pharma License Holdings Limited and Everest Medicines II Limited (Filed With SEC on March 14, 2019)
